Results 121 to 130 of about 42,372,924 (279)

D. Palmer to James C. Furman

open access: yes
A one page letter and envelope from D.
Palmer, D.
core  

Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy

open access: yesMolecular Oncology, EarlyView.
LCOR (Ligand‐dependent corepressor) mRNA encapsulated in polymeric nanoparticles restores LCOR activity in tumor cells, constraining aggressive tumor cell states and increasing tumor immunogenicity. This reprogramming makes tumor cells more vulnerable to T‐cell attack and enhances their response to immune‐checkpoint immunotherapy.
Gabriel Serra‐Mir   +9 more
wiley   +1 more source

R. F. and D. C. F. McEwin

open access: yes, 2007
"SX11030 R.F. McEwin 2'14 Aust Field Reg Served In Darwin July 1941 - Jan 1943 _____ SX11081 D.C.F. McEwin 2'14 Aust Field Reg Served In Darwin July 1941 - Jan 1943"SX11030 R. F.
McEwin, R. F., McEwin, D. C. F.
core  

Efficient display of an HCV cDNA expression library as C-terminal fusion to the capsid protein D of bacteriophage lambda

open access: yes, 1998
We describe the construction and characterization of a hepatitis C virus (HCV) cDNA expression library displayed as a fusion to the carboxy terminus of the capsid protein D of bacteriophage lambda, cDNA inserts were obtained by tagged random-priming of ...
C. Santini   +6 more
core   +1 more source

Tumour‐proximal deep serum proteomics identifies biomarkers associated with ovarian cancer

open access: yesMolecular Oncology, EarlyView.
New biomarkers are needed for early ovarian cancer detection. Ovarian (tumour‐proximal) and peripheral vein serum from healthy women and patients with benign or malignant tumours underwent nanoparticle‐enriched deep proteomics. Ovarian serum yielded more protein identifications and revealed tumour‐reflective signatures.
Darren Lau   +9 more
wiley   +1 more source

Attitudes of cancer patients toward ctDNA‐based liquid biopsy for follow‐up

open access: yesMolecular Oncology, EarlyView.
This mixed‐methods study explored cancer patients' experiences, knowledge, and preferences regarding ctDNA‐based liquid biopsy for follow‐up. Awareness of ctDNA was low and recall of previous liquid biopsy was imperfect, yet acceptance was high.
Siddharth Chhajlani   +7 more
wiley   +1 more source

Overcoming platinum resistance by the disulfiram metabolite CuET in novel preclinical models of human carcinomas

open access: yesMolecular Oncology, EarlyView.
Cisplatin‐resistant cancer cells survive DNA‐damaging platinum‐based treatment yet remain sensitive to CuET‐induced proteotoxic stress. The distinct mechanism of action allows CuET to overcome and eliminate cisplatin‐resistant tumour cells, unless highly expressed metallothioneins (MTs) interfere with CuET, thereby highlighting MT levels as candidate ...
Stefanos Arampatzis   +20 more
wiley   +1 more source

William D. Henderson to James C. Furman

open access: yes
A two page letter and envelope from William D.
Henderson, William D.
core  

Single‐molecule DNA flow‐stretch assays for high‐throughput DNA–protein interaction studies

open access: yesFEBS Open Bio, EarlyView.
We describe an optimised single‐molecule DNA flow‐stretch assay that visualises DNA–protein interactions in real time. Linear DNA fragments are tethered to a surface and stretched by buffer flow for fluorescence imaging. Using λ and φX174 DNA, this protocol enhances reproducibility and accessibility, providing a versatile approach for studying diverse ...
Ayush Kumar Ganguli   +8 more
wiley   +1 more source

[Stammbuch H. C. D. Kühn] [PDF]

open access: yes
[STAMMBUCH H. C. D. KÜHN] [Stammbuch H. C. D. Kühn] ( - ) Cover ( - ) Exlibris: Hans Stula ( - ) Besitzvermerk, vorderes Vorsatzblatt ([1]) Einträge, S. 12 - 31 (12) Einträge, S. 42 - 76 (42) Einträge, S. 77 - 104 (77)
Kühn, H. C. D.
core  

Home - About - Disclaimer - Privacy